These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26937020)

  • 1. Combined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal.
    Gerak LR; France CP
    J Pharmacol Exp Ther; 2016 May; 357(2):357-66. PubMed ID: 26937020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between μ-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration.
    Maguire DR; Yang W; France CP
    J Pharmacol Exp Ther; 2013 Jun; 345(3):354-62. PubMed ID: 23536317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys.
    Gerak LR; Zanettini C; Koek W; France CP
    Psychopharmacology (Berl); 2015 Oct; 232(19):3637-47. PubMed ID: 26202613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactive effects of (±)-trans-U50488 and its stereoisomers with cannabinoids.
    Erwin LL; Nilges MR; Denys IB; Sutphen JC; Friend AJ; Kapusta DR; Winsauer PJ
    Pharmacol Biochem Behav; 2021 Aug; 207():173218. PubMed ID: 34118232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs.
    Stewart JL; McMahon LR
    J Pharmacol Exp Ther; 2010 Jul; 334(1):347-56. PubMed ID: 20375197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of efficacy at the μ-opioid receptor on antinociceptive effects of combinations of μ-opioid receptor agonists and cannabinoid receptor agonists.
    Maguire DR; France CP
    J Pharmacol Exp Ther; 2014 Nov; 351(2):383-9. PubMed ID: 25194020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between Delta(9)-tetrahydrocannabinol and mu opioid receptor agonists in rhesus monkeys: discrimination and antinociception.
    Li JX; McMahon LR; Gerak LR; Becker GL; France CP
    Psychopharmacology (Berl); 2008 Aug; 199(2):199-208. PubMed ID: 18470505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
    Smith PA; Selley DE; Sim-Selley LJ; Welch SP
    Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A.
    Vivian JA; Kishioka S; Butelman ER; Broadbear J; Lee KO; Woods JH
    J Pharmacol Exp Ther; 1998 Aug; 286(2):697-703. PubMed ID: 9694923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventilatory-depressant effects of opioids alone and in combination with cannabinoids in rhesus monkeys.
    Weed PF; Gerak LR; France CP
    Eur J Pharmacol; 2018 Aug; 833():94-99. PubMed ID: 29807027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
    McMahon LR
    Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional consequences of short-term exposure to opioids versus cannabinoids in nonhuman primates.
    Ding H; Kiguchi N; Mabry KM; Kishioka S; Ko MC
    Neuropharmacology; 2023 Feb; 223():109328. PubMed ID: 36356937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids.
    Wilson-Poe AR; Pocius E; Herschbach M; Morgan MM
    Pharmacol Biochem Behav; 2013 Jan; 103(3):444-9. PubMed ID: 23063785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys.
    Negus SS; Mello NK
    Psychopharmacology (Berl); 2002 Jan; 159(3):275-83. PubMed ID: 11862360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice.
    Sim-Selley LJ; Martin BR
    J Pharmacol Exp Ther; 2002 Oct; 303(1):36-44. PubMed ID: 12235230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids.
    McMahon LR
    Br J Pharmacol; 2011 Mar; 162(5):1060-73. PubMed ID: 21091643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diltiazem enhances the analgesic but not the respiratory depressant effects of morphine in rhesus monkeys.
    Kishioka S; Ko MC; Woods JH
    Eur J Pharmacol; 2000 May; 397(1):85-92. PubMed ID: 10844102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol.
    Cichewicz DL; Welch SP
    J Pharmacol Exp Ther; 2003 Jun; 305(3):812-7. PubMed ID: 12606610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration.
    Gmerek DE; Dykstra LA; Woods JH
    J Pharmacol Exp Ther; 1987 Aug; 242(2):428-36. PubMed ID: 3302208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.